Three ways this metastatic breast cancer patient has made research participation a part of her life.
PUBLISHED January 11, 2019
Martha lives in Illinois and was diagnosed with metastatic breast cancer in January 2015. She has a husband and three children, ranging in age from 12 to 18, a dog and a lizard.
I've been so fortunate, at just over four years since my diagnosis of metastatic cancer, to still be on my first line of treatment (minus the Taxol). When the time comes to switch treatment for whatever reason, I know I'll be taking a look at clinical trials as well as a standard second line for HER2-positive metastatic breast cancer.
So, when people ask me if I've thought about clinical trials for my care I always hesitate. Sure, I've thought about them, but when something is working well, you don't decide to just change course. I've been asked enough times about clinical trials – in part because I try to remain informed about drugs and treatments that are in the pipeline – that I have sometimes felt I haven't been doing my part to advance the care of people like me and those who will someday face metastasis. If there's anything I can do to help improve care for these future patients, while also allowing me to be confident in my own treatment, I am there. For example:
No comments:
Post a Comment